Myonexus Therapeutics receives FDA Rare Pediatric Disease Designation
Credit: Myonexus Therapeutics NEW ALBANY, OH, May 16, 2018 -- Myonexus Therapeutics, a clinical-stage gene therapy company developing first ever corrective gene therapies for limb...


